Literature DB >> 6997331

Plasma glucagon and insulin concentrations in acromegaly.

E R Trimble, A B Atkinson, K D Buchanan, D R Hadden.   

Abstract

Sixteen patients with clinically active acromegaly were investigated; four of these had insulin-independent diabetes mellitus. Those acromegalic subjects who were not diabetic exhibited excessive insulin responses to glucose and arginine stimulation. By contrast, plasma glucagon concentrations in these patients did not differ significantly from those in control subjects. Acromegalic patients who also had insulin-independent diabetes had a markedly reduced insulin response to glucose stimulation, while arginine-induced insulin secretion was relatively well preserved. Although there was a tendency for plasma glucagon concentrations to be higher in the diabetic than in the nondiabetic group of acromegalic subjects, this difference did not achieve statistical significance either in the basal state or during the glucose amd arginine infusion tests.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997331     DOI: 10.1210/jcem-51-3-626

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.

Authors:  S Karlander; M Vranić; S Efendić
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

2.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

Authors:  Shoshana Yakar; Jennifer Setser; Hong Zhao; Bethel Stannard; Martin Haluzik; Vaida Glatt; Mary L Bouxsein; John J Kopchick; Derek LeRoith
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes.

Authors:  Raul M Luque; Qing Lin; José Córdoba-Chacón; Papasani V Subbaiah; Thorsten Buch; Ari Waisman; Hugo Vankelecom; Rhonda D Kineman
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

4.  The ability of β-cells to compensate for insulin resistance is restored with a reduction in excess growth hormone in Korean acromegalic patients.

Authors:  Soo Kyoung Kim; Sunghwan Suh; Ji In Lee; Kyu Yeon Hur; Jae Hoon Chung; Moon-Kyu Lee; Yong-Ki Min; Jae Hyeon Kim; Jong-Hyun Kim; Kwang-Won Kim
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

5.  The effect of long acting somatostatin analogue SMS 201-995 in acromegaly.

Authors:  C J Choi; D B Shin; S W Kim; I M Yang; J W Kim; Y S Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.